by | Sep 16, 2021 | Publications
BMJ Open. 2021 Sep 6;11(9):e045854. doi: 10.1136/bmjopen-2020-045854.ABSTRACTINTRODUCTION: Multiple myeloma (MM) is a plasma cell cancer where about 1/3 of the patients present with pathological fractures at the time of diagnosis. Despite treatment, the majority of...
by | Sep 14, 2021 | Publications
Anticancer Res. 2021 Sep;41(9):4305-4312. doi: 10.21873/anticanres.15235.ABSTRACTBACKGROUND/AIM: Multiple myeloma (MM) is characterized by high production of immunoglobulins resulting in a constant source of endoplasmic reticulum (ER)-stress. Mesencephalic...
by | Sep 14, 2021 | Publications
Blood Adv. 2021 Aug 24;5(16):3203-3215. doi: 10.1182/bloodadvances.2021004976.ABSTRACTSomatic mutations in UBA1 involving hematopoietic stem and myeloid cells have been reported in patients with the newly defined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory,...
by | Sep 11, 2021 | Publications
Medicine (Baltimore). 2021 Sep 3;100(35):e27131. doi: 10.1097/MD.0000000000027131.ABSTRACTThe evaluation of bone disease in multiple myeloma (MM) is an important topic in imaging. This study retrospectively investigated whole-body diffusion-weighted imaging (WB-DWI)...
by | Sep 7, 2021 | Publications
Orv Hetil. 2021 Sep 5;162(36):1451-1458. doi: 10.1556/650.2021.32179.ABSTRACTÖsszefoglaló. Bevezetés: A myeloma multiplex mindmáig alapvetően gyógyíthatatlan betegség, ezért nagy klinikai jelentőségük van az eredményes mentő kezeléseknek. A szájon át adható első...
by | Sep 7, 2021 | Publications
BMC Res Notes. 2021 Sep 4;14(1):346. doi: 10.1186/s13104-021-05758-7.ABSTRACTOBJECTIVE: Studies on the genetic background of patients with multiple myeloma (MM) have been increasing; two important factors considered in such works are uncoupling protein-2 (UCP-2) and...
